No study locations reported - 01 Sep `25Dexamethasone with light therapy for vitiligo

Dexamethasone with light therapy for vitiligo

Official title: Expression of CXCL11 & TEMRA in Serum of Vitiligo Patients Treated With Narrow-band UVB

Status: Opening soon

Description:

Assiut University plans to enroll about 40 participants. The study uses controlled ultraviolet light, sometimes with an immune-modulating medicine. UV light can stimulate surviving melanocytes and may help affected skin regain color. Possible effects include redness, itching, dryness, sunburn-like reactions, and with repeated exposure, premature skin aging or a higher skin-cancer risk. The study record does not list an age range. Recruitment has not started, and no locations are listed yet.

Start date: September 01, 2025

Completion date: September 30, 2026

Organizer: Assiut University

Contact: See contacts and locations in the ClinicalTrials.gov record

Link: https://clinicaltrials.gov/study/NCT06946069

Clinical Trial Alerts

Sign up and be the first to know about updates on this trial.

This request will be sent with the trial reference Dexamethasone with light therapy for vitiligo . By submitting you agree to our Privacy Policy.

FAQOther Questions

  • Does halo nevi affect vitiligo development?

    Halo nevi (also known as Sutton's nevi) are characterized by a mole that's surrounded by a ring of depigmented or lighter skin. While both halo nevi and vitiligo involve the des...

  • How long does it take to treat vitiligo?

    Vitiligo, a condition characterized by the loss of skin pigment, can be unpredictable in both progression and treatment. The time it takes to treat vitiligo varies significantly...

  • Vitiligo and Pregnancy

    Pregnancy with vitiligo? The good news: vitiligo itself doesn’t make pregnancy unsafe. Most women stay stable (some even improve), though flares can pop up after birth — usually...